Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Psoriatic arthritis
Vanessa Ocampo D, Dafna D. Gladman
F1000Research (2019) Vol. 8, pp. 1665-1665
Open Access | Times Cited: 143

Showing 1-25 of 143 citing articles:

The effect of exercise on cytokines: implications for musculoskeletal health: a narrative review
Sophie Docherty, Rachael Harley, Joseph J. McAuley, et al.
BMC Sports Science Medicine and Rehabilitation (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 156
Immunometabolism in the development of rheumatoid arthritis
Cornelia M. Weyand, Jörg J. Goronzy
Immunological Reviews (2020) Vol. 294, Iss. 1, pp. 177-187
Open Access | Times Cited: 127
Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review
Akshitha Thatiparthi, Amylee Martin, Jeffrey Liu, et al.
American Journal of Clinical Dermatology (2021) Vol. 22, Iss. 4, pp. 425-442
Open Access | Times Cited: 84
Vitamin D Deficiency, Osteoporosis and Effect on Autoimmune Diseases and Hematopoiesis: A Review
Massimo De Martinis, Alessandro Allegra, Maria Maddalena Sirufo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8855-8855
Open Access | Times Cited: 73
Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phase IIIb, randomised, controlled study (COSMOS)
Laura C. Coates, Laure Gossec, Elke Theander, et al.
Annals of the Rheumatic Diseases (2021) Vol. 81, Iss. 3, pp. 359-369
Open Access | Times Cited: 69
Current Status, Issues and Future Prospects of Personalized Medicine for Each Disease
Yuichi Yamamoto, Norihiro Kanayama, Yusuke Nakayama, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 3, pp. 444-444
Open Access | Times Cited: 43
The promise of precision medicine in rheumatology
Joel M. Guthridge, Catriona A. Wagner, Judith A. James
Nature Medicine (2022) Vol. 28, Iss. 7, pp. 1363-1371
Open Access | Times Cited: 43
Comorbidity in Adult Psoriasis: Considerations for the Clinician
Christine Daugaard, Lars Iversen, Kasper Fjellhaugen Hjuler
Psoriasis Targets and Therapy (2022) Vol. Volume 12, pp. 139-150
Open Access | Times Cited: 34
Risk Factors for Psoriasis Flares: A Narrative Review
Luca Potestio, Giuseppe Lauletta, Nello Tommasino, et al.
Psoriasis Targets and Therapy (2024) Vol. Volume 14, pp. 39-50
Open Access | Times Cited: 6
Thymic Stromal Lymphopoietin in Cutaneous Immune-Mediated Diseases
S. Wang, Ya‐Gang Zuo
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 39
Prevalence and Characteristics of Psoriasis in Romania—First Study in Overall Population
Alin Codruț Nicolescu, Ștefana Bucur, Călin Giurcăneanu, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 6, pp. 523-523
Open Access | Times Cited: 34
Types of Psoriasis and Their Effects on the Immune System
Anushka Dhabale, Shailesh Nagpure
Cureus (2022)
Open Access | Times Cited: 26
Real-world evidence for ixekizumab in the treatment of psoriasis and psoriatic arthritis: literature review 2016–2021
Adam Reich, Catherine Reed, Christopher Schuster, et al.
Journal of Dermatological Treatment (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 15
Is the patient-perceived impact of psoriatic arthritis a global concept? An international study in 13 Arab countries (TACTIC study)
Nelly Ziadé, Noura Abbas, Ihsane Hmamouchi, et al.
Rheumatology International (2024) Vol. 44, Iss. 5, pp. 885-899
Closed Access | Times Cited: 4
Use of risk chart algorithms for the identification of psoriatic arthritis patients at high risk for cardiovascular disease: findings derived from the project CARMA cohort after a 7.5-year follow-up period
Jessica Polo y La Borda, Santos Castañeda, Elena Heras-Recuero, et al.
RMD Open (2024) Vol. 10, Iss. 2, pp. e004207-e004207
Open Access | Times Cited: 4
Prevalence of psoriatic arthritis in Italy: insights from the multicentric MAPSI study
Teodora Şerban, Giuseppina Tramontano, Monica Pendolino, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Real-world clinical experience with secukinumab in psoriatic arthritis: an observational study and a literature review
Eleonora Celletti, Giulio Gualdi, Emanuela Sabatini, et al.
Reumatismo (2025)
Open Access
Beyond conventional care: exploring complementary and alternative medicine for autoimmune disorders
Marcel Katrib, Zahi Hamdan, Jamal Serhal, et al.
Reumatologia/Rheumatology (2025)
Open Access
Psoriatic arthritis in Jordan: a cross-sectional study of disease characteristics, patient-reported outcomes, and disease activity
Fatima Alnaimat, Khaldoon Alawneh, Ayman AbuHelal, et al.
BMC Rheumatology (2025) Vol. 9, Iss. 1
Open Access
Synergistic Improvements in Synovitis, Enthesitis, and Patient-Reported Outcomes for Patients with Psoriatic Arthritis Treated with Ixekizumab in SPIRIT Trials
Lars‐Erik Kristensen, Dennis McGonagle, Martín Rudwaleit, et al.
Rheumatology and Therapy (2025)
Open Access
Real-World Experience with an Adalimumab Biosimilar (ABP 501) in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis and Psoriasis in Europe: Results from the Adelphi Disease Specific Programme
Ran Jin, James Haughton, Emily J. Goddard, et al.
Rheumatology and Therapy (2025)
Open Access
Proteomic biomarkers in psoriatic arthritis
Márcia Regina Rosa Scalcon, Aline Josiane Waclawovsky, Felipe Barreto Schuch, et al.
Clinica Chimica Acta (2025), pp. 120244-120244
Closed Access
The game-changer: ultrasound examination of distal interphalangeal joint swelling and nail psoriasis
Matteo Ferrito, Romano Fabbri, Silvia Sirotti, et al.
Annals of the Rheumatic Diseases (2025)
Closed Access
Recent Advances in Gut Microbiota in Psoriatic Arthritis
Maria Grazia Bonomo, Salvatore D’Angelo, Valentina Picerno, et al.
Nutrients (2025) Vol. 17, Iss. 8, pp. 1323-1323
Open Access
The use of selective Janus kinase inhibitor upadacitinib in a patient with psoriatic arthritis (clinical observation)
Yu. A. Lushpaeva
Modern Rheumatology Journal (2025) Vol. 19, Iss. 2, pp. 98-101
Open Access
Page 1 - Next Page

Scroll to top